Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon, Spain

American Journal of Tropical Medicine and Hygiene

Volumn 71, Issue 4, 2004, Pages 403-406

  Garrote, José I ^a   Gutiérrez, M Purificacion ^a   Izquierdo, Raúl López ^a   Dueñas, M Ana I ^a   Zarzosa, Pilar ^b   Canavate, Carmen ^c   El Bali, M ^c   Almaraz, Ana ^b   Bratos, Miguel A ^a   Berbel, Clara ^d   Rodríguez Torres, Antonio ^a   Domingo, Antonio Orduña ^b,e  

^a Facultad de Medicina   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Servicio de Programas de Salud y Prevención de la Dirección Técnica de Recursos Humanos y Gestión de Centros Gerencia de Servicios Sociales   (Spain)

^e UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; DISEASE TRANSMISSION; DRUG USE; ENZYME IMMUNOASSAY; FEMALE; GENDER; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LEISHMANIA INFANTUM; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; RURAL AREA; SEROPREVALENCE; SPAIN;

CASTILLA; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA INFANTUM; PROTOZOA;

EID: 7644241004     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2004.71.403     Document Type: Article

References (18)

1. Anonymous, 2000. Leishmaniasis and leishmania/HIV co-infection. WHO Report on Global Surveillance of Epidemic-Prone Infections Diseases. Geneva: World Health Organization. WHO/CDS/CSR/ISR/2000.1, 121-127.
2. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, Lopez-Vélez R, Molina R, Moreno J, 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10: 298-319.
3. Alvar J, Gutiérrez-Solar B, Pachon I, Calbacho E, Ramírez M, Vallès R, Guillén JL, Cañavate C, Amela C, 1996. AIDS and Leishmania infantum. New approaches for a new epidemiogical problem. Clin Dermatol 14: 541-546.
4. Acedo C, Martín J, Vélez ID, Sanchís MC, Louassini M, Maldonado JA, Morillas F, 1996. Leishmaniasis eco-epidemiology in the Alpujarra region (Granada province, southern Spain). Int J Parasitol 25: 303-310.
5. Morillas F, Sánchez F, Ocaña J, Martín-Sánchez J, Ocaña-Wihelmi J, Acedo C, Sanchiz-Marín MC, 1996. Leishmaniosis in the focus of the Axarquía region, Málaga province, southern Spain: a survey of the human, dog, and vector. Parasitol Res 82: 569-570.
6. Botet J, Portús M, 1993. La leishmaniosis en la España Peninsular. Revision hiseorico-bibliográfica (1912-1985). Rev San Hig Publica 67: 255-266.
7. Centro National de Epidemiología, 1996. Instituto de Salud Carlos III (España). Bol Epidemiol Semin 4: 393-404.
8. Moral L, Rubio EM, Moya M, 2002. A leishmanin skin test survey in the human population of l'Alacanti region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe. Trans R Soc Trop Med Hyg 96: 129-132.
9. Medrano FJ, Cañavate C, Leal M, Rey C, Lissen E, Alvar J, 1998. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg 59: 155-162.
10. Pintado V, Martín-Rabadán P, Rivera ML, Moreno S, Bouza E, 2001. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) 80: 54-73.
11. Scott P, Pearce E, Natovitz P, Sher A, 1987. Vaccination against cutaneous leishmaniasis in a murine model. J Immunol 139: 221-227.
12. Marty P, Lelievre A, Quaranta JF, Rahal A, Gari-Toussaint M, Le Fichoux Y, 1994. Use of the leishmanin skin test and Western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg 88: 658-659.
13. Bettini S, Gramiccia M, Gradoni L, Pozio E, Mugnai S, Maroli M, 1983. Leishmaniasis in Tuscany (Italy): VIII. Human population response to leishmanin in the focus of Monte Argentario (Grosseto) and epidemiological evaluation. Ann Parasitol Hum Comp 58: 539-547.
14. Gutiérrez J, Maroto MC, Piédrola G, Higuera A. 1993. Prevalencia de anticuerpos anti-Leishmania en individuos adictos a drogas por vía parenteral. Rentabilidad de dos técnicas de estudio. Med Clin (Barc) 100: 168-170.
15. Kar K, 1995. Serodiagnosis of leishmaniasis. Crit Rev Microbiol 21: 123-152.
16. Wernek GL, Rodrigues L, Santos MV, Araujo IB, Moura LS, Lima SS, Gomes RBB, Maguire JH, Costa CHN, 2002. The burden of Leishmania chagasi infection during an urban outbreak of visceral leishmaniasis in Brazil. Acta Trop 83: 13-18.
17. Evans TG, Teixeira MJ, McAuliffe IT, Vasconcelos I, Vasconcelos AW, de Queiroz Sousa A, Oliveira Lima JW, Pearson RD, 1992. Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 166: 1124-1132.
18. El-Safi SH, Buchelon B, Kheir MM, Musa HA, El-Obaid M. Hammad A, Dessein A. 2002. Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997). Microbes Infect 4: 1439-1447.